BioCentury
ARTICLE | Emerging Company Profile

AgomAb: antibodies driving tissue regeneration and recovery

Emerging Company Profile: argenx spinout AgomAb raises $74M series B to complete clinical POC for lead mAb and grow pipeline

March 11, 2021 10:33 PM UTC

AgomAb parlayed what began as a cancer drug discovery partnership into an antibody program that could drive tissue regeneration and organ recovery.  On Wednesday, the Belgian biotech raised $74 ...



Access this Article